Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceutical Cartridges
... at a CAGR of 6.7% over the analysis period 2023-2030. Glass Material, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Native Collagen
... at a CAGR of 5.9% over the analysis period 2023-2030. Bovine Source, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$130.6 Million by the end of ... Read More
-
Pharmaceutical Analytical Testing Outsourcing
... reach US$16.3 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Bioanalytical Testing Service, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and ... Read More
-
Orphan Drugs
... at a CAGR of 11.9% over the analysis period 2023-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$286.3 Billion by the end of ... Read More
-
Calcium Channel Blockers
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Dihydropyridine Drug Class, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$17.1 Billion ... Read More
-
Myeloproliferative Disorders Drugs
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Ph+ Chronic myelogenous leukemia (CML) Drugs, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and ... Read More
-
Nanocapsules
... of 6.3% over the analysis period 2023-2030. Oncology Therapy Area, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Sarcoma Drugs
... at a CAGR of 7.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Anticholinergic Drugs
... at a CAGR of 5.0% over the analysis period 2023-2030. Synthetic Compounds, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$6.6 Billion by the end of ... Read More
-
Sodium Alginate
... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More
-
Pharmaceutical Processing Seals
... by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. O-Rings, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.8 Billion by the ... Read More
-
Anti-Platelet Agents
... at a CAGR of 6.6% over the analysis period 2023-2030. Hospital Pharmacies Distribution Channel, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.3 Billion by the ... Read More
-
Personalized Nutrition
... at a CAGR of 13.5% over the analysis period 2023-2030. Active Measurement, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$27.5 Billion by the end of ... Read More
-
Pharmaceutical Robots
... at a CAGR of 7.6% over the analysis period 2023-2030. Traditional Robots, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$224.1 Million by the end of ... Read More
-
Sustained Release Excipients
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Bio Decontamination
... at a CAGR of 4.6% over the analysis period 2023-2030. Bio Decontamination Equipment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$122.1 Million by the end ... Read More
-
Proanthocyanidins
... of 6.2% over the analysis period 2023-2030. Cranberry Source, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$177.2 Million by the end of the analysis period. ... Read More
-
Epilepsy Drugs
... at a CAGR of 3.8% over the analysis period 2023-2030. First Generation Epilepsy Drugs, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.6 Billion by the ... Read More
-
Pharmaceutical Filtration
... at a CAGR of 17.0% over the analysis period 2023-2030. Membrane Filters, one of the segments analyzed in the report, is expected to record a 21.0% CAGR and reach US$19.6 Billion by the end of ... Read More
-
Urothelial Cancer Drugs
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$13.3 Billion by the ... Read More
-
Penicillin Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
White Oil Market - A Global and Regional Analysis: Focus on Application, Functionality, Grade, Products, and Country Level Analysis - Analysis and Forecast, 2024-2034
... a diverse range of highly refined, mineral-based oils used across various industries, including pharmaceuticals, cosmetics, food processing, and industrial applications. Driven by the increasing demand for purity and safety in product formulations, white oil serves ... Read More
-
Gelatin Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
Americas, Asia, and North Africa Flexible Packaging Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Paper and Plastic), Packaging Type (Pouches, Rollstock, Bags, Films and Wraps, and Others), End Use [Food (Dairy Products, Fruits and Vegetables, Meat Poultry and Seafood, Bakery and Confectionery, RTE Foods, and Others), Beverages, Pharmaceutical, Personal Care and Cosmetics, Homecare Products, and Others], and Geography
... Wraps, and Others), End Use [Food (Dairy Products, Fruits and Vegetables, Meat Poultry and Seafood, Bakery and Confectionery, RTE Foods, and Others), Beverages, Pharmaceutical, Personal Care and Cosmetics, Homecare Products, and Others], and Geography The ... Read More
-
Global Pharmaceutical Analytical Testing Outsourcing Market 2024-2028
... during the forecast period. The report on the pharmaceutical analytical testing outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. ... Read More
Research Assistance
